Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Suzanne is a content marketer, writer, and ...

Claire Boyte-White is the lead writer for NapkinFinance.com, co-author of I Am Net Worthy, and an Investopedia contributor. Claire's expertise lies in corporate finance & accounting, mutual funds, ...

Earnings Call Insights: NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 The company reiterated its fiscal year 2025 guidance, expecting product revenue to be in the range of $8 million to $10 ...

Medical device company ResMed (NYSE:RMD) reported Q2 CY2025 results beating Wall Street’s revenue expectations , with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per ...

Financial services giant Prudential Financial (NYSE:PRU) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 2.5% year on year to $13.51 billion. Its non-GAAP profit of $3.58 ...

Medical device company ResMed (NYSE:RMD) reported Q2 CY2025 results , with sales up 10.2% year on year to $1.35 billion. Its non-GAAP profit of $2.55 per share was 3% above analysts’ consensus ...

The company reiterated its fiscal year 2025 guidance, expecting product revenue to be in the range of $8 million to $10 million, representing an increase of between 132% and 190% over fiscal year 2024 ...

Management expects "revenue to show continued sequential growth in the second half of 2025." Bercovich stated, "Looking ahead, we expect that this burn rate to decrease in the second half of the year, ...

Gurit: decline in net sales but growth in operating margin in the first half of 2025 For the first quarter of 2025, Swiss company Gurit has announced unaudited net sales of CHF 164.7 million ...

Total Net Revenues-- Total net revenues increased by 36.8% to RMB1.09 billion in 2025, primarily due to a 78.7% year-over-year increase in net revenues from skincare brands and an 8.8% year-over-year ...

~ Record Adjusted Gross Margin - 60.6%, up from 42.7% last quarter ~ ~ Strong Adjusted Gross Profit Growth - up 32.7% from last quarter and 71.6% Y/Y ~ ~ Year-over-Year Revenue Growth - $2.35M up 14.2 ...